Catherine Monk, PhD, is a Professor in the Departments of Obstetrics & Gynecology and Psychiatry at Columbia University Irving Medical Center and Research Scientist VI at the New York State Psychiatric Institute. Dr. Monk oversees the integrated women’s mental health program in Obstetrics & Gynecology. Dr. Monk’s research brings together the fields of psychopathology, developmental psychobiology, developmental neuroscience, and perinatal psychiatry to focus on the earliest influences on children’s developmental trajectories—those that happen in utero—and how to intervene early to prevent mental health problemsJian Jenny Tang
Dr. Jian Jenny Tang has over 20 years of experience in general obstetrics and gynecology. Dr. Tang is an advocate for her patients by balancing modern western medicine and holistic eastern medicine. Dr. Tang also has a strong interested in reproductive health and women’s wellness. Lastly, she is involved in the North America Asian American fitness community, providing health and exercise guidelines to women before, during and after pregnancy.Shailja Dixit
Dr. Dixit is a Physician Executive with more than 20 years of experience in the healthcare and life sciences industry. She has been in executive leadership at Sanofi, Allergan, and GE and has been responsible for launching a number of innovative medicines. She was voted innovator of the year at GE in 2008, nominated as a Top 50 Thought Leader in “Big Data” in Life Sciences in 2016, and featured in the Pharma Executive Magazine cover-page article “Real-World Evidence: From Volume to Value” (Oct 13, 2016). Shailja has built and has had successful exits with many projects.University of CoimbraBeAMomErin Russell
Healthcare executive with extensive experience in Product, Marketing, and Commercial. Founder of Health Grizzly, a digital health platform helping seniors access care. Founder and General Manager of Spotlyte, a digital health venture focused on facilitating the consumer journey into treatment through education and engagement. In addition to her entrepreneurial experience, Erin has 20+ years commercial experience at pharmaceutical companies, including Merck, Schering-Plough, and Allergan. She has built and led commercial teams and business units, launched products, and reinvigorated sales of in-line products. Erin holds a B.S. in Chemistry from University of Arizona and an M.B.A. from Harvard Business School.Komal Dutt, PhD
Dr. Komal Dutt received her Ph.D. from State University of New York at Albany. She has completed an American Psychological Association approved internship at University of Pittsburgh Counseling Center and has completed her post-doctoral training at Drew University Counseling Center. She has also worked at a community mental health center in upstate N.Y. She received a Masters in Organizational Behavior from University of Delhi, India. She is skilled in treatment of depression, anxiety, stress, relationship issues, self-esteem, body-image, women’s, and career related issues.Ana Fonseca, PhD
Dr. Fonseca is post doctoral fellow at university if Coimbra, Portugal. She has conducted multiple years of research and published several studies in area of post-partum depression. Her research led to development of beamom program. Be a Mom is a selfguided, web-based intervention to prevent persistent postpartum depression symptoms [PPD], targeting both at-risk postpartum women and/or women presenting early-onset postpartum depressive symptoms. Be a Mom is grounded on the principles of Cognitive-Behavior Therapy. CurioTM has exclusive right to beamom content and principles have been incorporated in Stella program.Robert Honigberg, MD, MBA
Robert Honigberg, MD, MBA. Robert is a former surgeon and an experienced clinical leader in a variety of therapeutic areas who taught strategy as a former Adjunct Professor of Health Enterprise Management at Kellogg Business School/ Northwestern University. He is the former Chief Medical Officer of GE Healthcare. He has also held positions of medical leadership in clinical development, business development, and medical affairs at Schering-Plough Oncology, Ortho Biotech, CardioDx, Flexion Therapeutics, Baxalta and Shire. He has designed and executed a myriad of clinical studies and is a current member of the MAPS Evidence Generation Focus Area working group Dr. Honigberg is a graduate from Duke University with a BA in Economics, obtained his medical degree and later MBA from Kellogg School of Management.Mark Devlin
Mark is a CurioTM Director and Executive with more than 30 years of experience in the biopharmaceutical industry. He is a former SVP of Market Access at Allergan, held similar positions at Actavis and Forest Laboratories, and has a deep understanding of the US payer system. He has also consulted for more than a dozen pharma clients, helping with commercial strategy, Hub and patient services, pricing strategy, and business development. Mark has a BS in Biology and Chemistry from Fairleigh Dickinson University and studied at the FW Olin School of Business at Babson College.